3. As of noon trading, Novartis ( NVS) is up $0.47 (0.8%) to $61.02 on light volume Thus far, 535,636 shares of Novartis exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $60.69-$61.17 after having opened the day at $60.81 as compared to the previous trading day's close of $60.55.

Novartis AG, through its subsidiaries, engages in the research, development, manufacture, and marketing of healthcare products worldwide. Novartis has a market cap of $146.9 billion and is part of the drugs industry. The company has a P/E ratio of 16.1, below the S&P 500 P/E ratio of 17.7. Shares are up 5.9% year to date as of the close of trading on Tuesday. Currently there are 6 analysts that rate Novartis a buy, 1 analyst rates it a sell, and 1 rates it a hold.

TheStreet Ratings rates Novartis as a buy. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, increase in stock price during the past year, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Novartis Ratings Report now.

Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade

If you liked this article you might like

New Teva CEO Just Added Nearly 13% to Company's Market Cap Without Even Starting

AstraZeneca Spikes After Lung Cancer Treat Study Shows 'Encouraging' Results